文献速递骨软组织肉瘤与黑色素瘤

前哨淋巴结阳性黑色素瘤的风险分层界定手术与辅助治疗考量

Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.
PubMed 文献 · Eur J Cancer · 2018-04-13

该回顾性队列纳入9个EORTC黑色素瘤中心的1015例前哨淋巴结阳性患者,按AJCC标准分期并根据溃疡和SN肿瘤负荷分层。仅用溃疡和SN肿瘤负荷的模型预测能力与包含CLND后亚分期的模型相当,可分出低、中、高危三组,提示省略CLND影响较小。

要点

  • 仅基于溃疡和SN肿瘤负荷即可对SN阳性患者进行有效风险分层。
  • CLND可使19%患者N分期升级、5-6%患者AJCC分期升级。
  • 分层所得低、中、高危组可指导辅助治疗决策。

核心结论

  • 基于溃疡和SN肿瘤负荷类别可对SN阳性患者进行充分分层,识别低、中、高危患者以指导辅助治疗,省略CLND似乎影响较小。

研究设计与样本

  • 回顾性队列研究,来自9个欧洲癌症研究与治疗组织(EORTC)黑色素瘤中心,共1015例 eligible 患者。
  • 患者基于SLNB和CLND结果按美国癌症联合委员会(AJCC)标准分期,并按溃疡和SN肿瘤负荷分层。
  • 分层因素纳入Cox回归模型,预测能力用Harrell一致性指数(c-index)和赤池信息量准则(AIC)评估。

主要发现

  • CLND导致19%患者N分类升级,5-6%患者AJCC分期升级。
  • 仅包含溃疡和SN肿瘤负荷的模型与包含CLND后亚分期的模型预测能力相当。
  • 包含基于SLNB亚分期的模型预测能力最低。
  • 按溃疡和SN肿瘤负荷分层得到四个SN阳性组,并从中可得出低、中、高危预后类别。

临床怎么用

  • 临床可基于溃疡和SN肿瘤负荷对SN阳性黑色素瘤患者进行风险分层,指导辅助治疗选择。
  • 省略完成性淋巴结清扫(CLND)对分层和预后判断影响较小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In light of the evolving landscape of adjuvant therapy in melanoma and the recently confirmed absent survival benefit of completion lymph node dissection (CLND), it becomes important to explore possible consequences of omitting CLND, and whether it is possible to adequately stratify positive sentinel node (SN) patients solely based on information retrieved from the melanoma up to the sentinel lymph node biopsy (SLNB). METHODS: A retrospective cohort from nine European Organization for Research and Treatment of Cancer Melanoma Group centres was used. Patients were staged based on SLNB and CLND result according to the American Joint Committee on Cancer (AJCC) criteria and stratified by ulceration and SN tumour burden. These were incorporated in Cox regression models. Predictive ability was assessed using Harrell's concordance index (c-index) and the Akaike information criterion (AIC). RESULTS: In total, 1015 patients were eligible. CLND led to upstaging in N-category in 19% and in AJCC stage in 5-6%. The model incorporating only ulceration and SN tumour burden performed equally well as the model incorporating substages after CLND. The model incorporating substages based on SLNB had the lowest predictive ability. Stratifying by ulceration and SN tumour burden resulted in four positive SN groups from which low-, intermediate- and high-risk prognostic classes could be derived. CONCLUSIONS: Adequate stratification of positive SN patients was possible based on ulceration and SN tumour burden category. The identification of low-, intermediate- and high-risk patients could guide adjuvant therapy in clinical practice. Omitting CLND seems to have little consequences.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Verver D, van Klaveren D, van Akkooi ACJ, et al. Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations. Eur J Cancer. 2018. PMID: 29660597. doi:10.1016/j.ejca.2018.02.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。